Kevin John Conway serves as Executive at Generation Bio Co., where they oversee executive responsibilities. Since joining the company, Kevin John Conway has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 15, 2026 involved exercising options for 59 shares valued at $0.
Kevin John Conway currently holds 235 shares of Generation Bio Co. (GBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin John Conway has been a net neutral trader of GBIO stock. They have purchased $0 and sold $0 worth of shares.
Kevin John Conway's most recent insider trade was on Jan 15, 2026, when they sold 59 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.64 |
| Discretionary |
| Jan 15, 2026 | GBIO | $0 | Option Exercise | 59 | $N/A | Discretionary |
| Oct 15, 2025 | GBIO | $0 | Option Exercise | 58 | $N/A | Discretionary |
| Oct 15, 2025 | GBIO | $121 | Payment | 18 | $6.71 | Discretionary |
| Jul 15, 2025 | GBIO | $0 | Option Exercise | 587 | $N/A | Discretionary |
| Jul 15, 2025 | GBIO | $74 | Payment | 173 | $0.43 | Discretionary |